This news is for those people who are interested in knowing which company is offering IPO so that can purchase it. It looks like one more firm is ready to issue their IPO and they completed all their paperwork. The reports are stating that 2 firms lodged their preliminary IPO papers with the capital markets regulator between the month of August, Follow Our website TheGossipsWorld Media for the latest updates on Business News!!!!!
Vaibhav Gems Get Sebi’s Approval To Float IPOs
And the month of September and get their observation letters. In order to know things in detail, just keep on reading this blog, so that you will get the right details that you all want, As per the latest report, Rare Enterprises-backed regional jewellery brand and Concord Biotech Vaibhav Gems N’Jewellers have got the capital markets regulator permission of Sebi in order to raise their funds with the help
Concord Biotech IPO, Vaibhav Gems Get Sebi’s Approval
Of initial public offerings (IPOs). As we already mentioned above, 2 firms lodged their preliminary IPO papers along with the stock exchange regulator between the month of August and September and get their observation letters at the time of 28th November to 2nd December 2022 an update with the Securities and Exchange Board of India (Sebi) which viewed on Tuesday, 6th November 2022.
In the terminology of Sebi, its observations imply its permission in order to float the sales of initial shares. As per papers that are drafted, the IPO of Concord Biotech is wholly an offer for the sale of OFS of the equity share of 2,09.25,652 by the side of Helix Investment Holdings Pte Limited which is supported by Quadria Capital which is an equity company. Now those who are looking to know
More about the firm Concord, it is among the directing producers of turmoil-based biopharmaceutical APIs aimed at niche segments for example anti-fungal, immunosuppressant, anti-bacterial, and oncology. This firm has 3 producing facilities in Gujarat which are Limbasi, Valthera, and Dholka. As we mentioned above this firm is supported by Rare Enterprises and Quadria Captial Fund
Which was created or established by Rakesh Jhunjhunwala who is one of the most popular billionaire investors. He created it with his spouse named Rekha. Sadly, in the month of August 2022, Rakesh was handed away and now his widow is looking at everything. According to other reports, a biopharma company which is based in Ahmedabad organized a portfolio of 65 products and 56 brands which
Includes 43 formulations and 22 APIs following the month of March 2022. The reports state that the IPO of Vaibhav Gems N’ Jewellers consists of a new issue of equity shares adding up to Rs 210 crore and OFS of the equity shares of 43 lakh by the advocate commodity Grandhi Bharata Mallika Ratna Kumari (HUF). To know more be with us and do not forget to read further articles.